Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other financing activities (2022 - 2025)

Rxo's Other financing activities history spans 4 years, with the latest figure at $11.0 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 450.0% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $1.0 million, down 90.91%, while the annual FY2025 figure was $1.0 million, 90.91% down from the prior year.
  • Other financing activities reached $11.0 million in Q4 2025 per RXO's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $11.0 million in Q4 2025 to a low of -$11.0 million in Q1 2025.
  • Average Other financing activities over 4 years is $2.1 million, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Other financing activities: changed 0.0% in 2023, then soared 900.0% in 2024.
  • A 4-year view of Other financing activities shows it stood at $8.0 million in 2022, then tumbled by 87.5% to $1.0 million in 2023, then skyrocketed by 100.0% to $2.0 million in 2024, then surged by 450.0% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Other financing activities are $11.0 million (Q4 2025), $1.0 million (Q2 2025), and -$11.0 million (Q1 2025).